Abstract:As Crohn’s disease (CD) has become more and more common in developing countries, tuberculosis still remains relatively common, thus differentiating CD from intestinal tuberculosis poses a great challenge to clinicians’ worldwide. There have been no good diagnostic methods until now. Recently, more cases using the TSPOT.TB test, an interferon-gamma (IFN-c) release assay of whole blood, could be highly specific for Mycobacterium tuberculosis. A 61-year-old male had abdominal distension and irregular stooling for 20 years. For the past 10 years his abdominal pain was more noticeable and was accompanied with green mucosy stools. His condition became more severe 2 years ago with right lower quadrant (RLQ) pain, nausea, and vomiting. B ultrasound showed a hypoechoic mass in the right lower quadrant diagnosed as ‘‘appendix abscess.’’ A second B ultrasound showed disappearance of the mass following antibiotic therapy. However, during the last year the RLQ pain returned and he underwent surgery to relieve intestinal obstruction caused by appendicitis and intestinal adhesions. One month later a partial colonoscopic examination was performed but inflammation and stricturing prevented a full examination. Double contrast barium enema showed stricturing and shortening of the ileocecum, ascending colon, and hepatic flexure. A second colonoscopy was successful and revealed ulceration of the cecum and ascending colon. Histology showed chronic inflammation. At the same time the patient also complained of severe pain in his joints. The medical team suspected CD or intestinal tuberculosis (TB). Differentiating CD from TB can be quite difficult. In this case our patient had a negative tuberculin test, but a strong positive T-SPOT result. Later, because the patient also had articule cavity dropsy, we obtained fluid from the cavity, which was found to contain tuberculosis antibodies, suggesting he had intestinal TB. We commenced antituberculosis treatment, which improved the patient’s clinical symptom and endoscopic presentation (Fig. 1). A second case was a 35-year-old female suffering from recurrent abdominal pain for 2 years which became more severe over 20 days. Colonoscopy showed multiple ulcers in the ascending colon and ileocecus and was diagnosed with CD. The T-SPOT assay was performed and was positive. FIGURE 1. Left: Patient’s ileocecal junction in an endoscopic image: obvious congestion, edema, erosion, and ulcer before antituberculosis therapy. Right: After antituberculosis treatment the mucosa looks normal. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Interferon-gamma release assays as a tool for differential diagnosis of gastrointestinal tuberculosis

The Diagnostic Efficiency Evaluation of Combination Tuberculosis Interferon-Gamma Release Assay with Human Leukocyte Antigen-G for Tuberculosis

Differentiating Crohnʼs Disease from Intestinal Tuberculosis Using an Interferon Gamma Release Assay

Recognizing and addressing the challenges of gastrointestinal tuberculosis

Interferon-Gamma Release Assays For The Diagnosis Of Active Tuberculosis In Hiv-Infected Patients: A Systematic Review And Meta-Analysis

THE ROLE OF INTERFERON-GAMMA RELEASE ASSAYS IN DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN CHILDREN

The In-Vitro Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis and Mycobacterium Tuberculosis Infections

Usefulness of Interferon-Γ Release Assay for the Diagnosis of Sputum Smear-Negative Pulmonary and Extra-Pulmonary TB in Zhejiang Province, China

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Gastrointestinal tuberculosis: Diagnostic approaches for this uncommon pathology

New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis

Interferon-Gamma Release Assay Performance of Pleural Fluid and Peripheral Blood in Pleural Tuberculosis

Diagnostic barriers in gastrointestinal tuberculosis

[Interferon Gamma Release Assay Request Indications: From Laboratory to Clinical Perspective]

Evaluation of Gamma Interferon Release Assays Using Mycobacterium Tuberculosis Antigens for Diagnosis of Latent and Active Tuberculosis in Mycobacterium Bovis Bcg-Vaccinated Populations

Effect of Adjusted Cut-Offs of Interferon-Γ Release Assays on Diagnosis of Tuberculosis in Patients with Fever of Unknown Origin.

Positive rates of interferon-γ release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests

Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.

Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country

Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis

Interferon-Gamma Release Assay Performance In Pulmonary And Extrapulmonary Tuberculosis